Correlation Between Protalix Biotherapeutics and Corvus Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Protalix Biotherapeutics and Corvus Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Protalix Biotherapeutics and Corvus Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Protalix Biotherapeutics and Corvus Pharmaceuticals, you can compare the effects of market volatilities on Protalix Biotherapeutics and Corvus Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Protalix Biotherapeutics with a short position of Corvus Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Protalix Biotherapeutics and Corvus Pharmaceuticals.
Diversification Opportunities for Protalix Biotherapeutics and Corvus Pharmaceuticals
-0.52 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Protalix and Corvus is -0.52. Overlapping area represents the amount of risk that can be diversified away by holding Protalix Biotherapeutics and Corvus Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Corvus Pharmaceuticals and Protalix Biotherapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Protalix Biotherapeutics are associated (or correlated) with Corvus Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Corvus Pharmaceuticals has no effect on the direction of Protalix Biotherapeutics i.e., Protalix Biotherapeutics and Corvus Pharmaceuticals go up and down completely randomly.
Pair Corralation between Protalix Biotherapeutics and Corvus Pharmaceuticals
Considering the 90-day investment horizon Protalix Biotherapeutics is expected to under-perform the Corvus Pharmaceuticals. But the stock apears to be less risky and, when comparing its historical volatility, Protalix Biotherapeutics is 2.04 times less risky than Corvus Pharmaceuticals. The stock trades about -0.42 of its potential returns per unit of risk. The Corvus Pharmaceuticals is currently generating about -0.07 of returns per unit of risk over similar time horizon. If you would invest 488.00 in Corvus Pharmaceuticals on December 16, 2024 and sell it today you would lose (36.00) from holding Corvus Pharmaceuticals or give up 7.38% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Protalix Biotherapeutics vs. Corvus Pharmaceuticals
Performance |
| Timeline |
| Protalix Biotherapeutics |
| Corvus Pharmaceuticals |
Protalix Biotherapeutics and Corvus Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Protalix Biotherapeutics and Corvus Pharmaceuticals
The main advantage of trading using opposite Protalix Biotherapeutics and Corvus Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Protalix Biotherapeutics position performs unexpectedly, Corvus Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Corvus Pharmaceuticals will offset losses from the drop in Corvus Pharmaceuticals' long position.| Protalix Biotherapeutics vs. Corvus Pharmaceuticals | ||
| Protalix Biotherapeutics vs. Aldeyra | ||
| Protalix Biotherapeutics vs. Checkpoint Therapeutics | ||
| Protalix Biotherapeutics vs. Cidara Therapeutics |
| Corvus Pharmaceuticals vs. Mereo BioPharma Group | ||
| Corvus Pharmaceuticals vs. Terns Pharmaceuticals | ||
| Corvus Pharmaceuticals vs. PDS Biotechnology Corp | ||
| Corvus Pharmaceuticals vs. Inozyme Pharma |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Transformation module to use Price Transformation models to analyze the depth of different equity instruments across global markets.
Other Complementary Tools
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges |
Recommendations on macroaxis.com are based on what is currently trending. Macroaxis LLC is not a registered investment advisor or broker/dealer.
The information on the site should be used for informational purposes only and is not investment advice.
more